Windtree Therapeutics, Inc. (WINT)
0.0103
0.00 (0.00%)
USD |
OTCM |
Apr 02, 15:07
Windtree Therapeutics Research and Development Expense (TTM) : 8.129M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Agenus, Inc. | 79.34M |
| Curis, Inc. | 28.25M |
| Plus Therapeutics, Inc. | 8.379M |
| Viskase Holdings, Inc. | -- |
| Halozyme Therapeutics, Inc. | 81.49M |